Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maya Zlotnik"'
Autor:
Naama Keren-Froim, Gabriel Heering, Gal Sharvit, Maya Zlotnik, Arnon Nagler, Avichai Shimoni, Abraham Avigdor, Jonathan Canaani
Publikováno v:
Annals of Hematology. 101:309-316
Early mortality remains a challenging therapeutic facet of the initial induction phase of intensive chemotherapy in patients with acute myeloid leukemia (AML). The impact of standard molecular evaluation and risk category of the European LeukemiaNet
Autor:
Arnon Nagler, Jonathan Canaani, Gal Sharvit, Abraham Avigdor, Gabriel Heering, Maya Zlotnik, Avichai Shimoni, Drorit Merkel
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(2)
Achievement of initial remission remains the most important clinical factor predicting long term survival in acute myeloid leukemia (AML) patients treated with intensive chemotherapy. Yet, whether the patient subset in need of a second cycle of inten
Autor:
Avichai Shimoni, Roni Shouval, Maya Zlotnik, Ronit Yerushalmi, Aniela Shouval, Joshua A Fein, Ivetta Danylesko, Arnon Nagler, Noga Shem-Tov
Clinical decisions in allogeneic hematopoietic stem cell transplantation (allo-HSCT) are supported by the use of prognostic scores for outcome prediction. Scores vary in their features and in the composition of development cohorts. We sought to exter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dcbc8545e9fd5154b1942cbf9b18213
https://europepmc.org/articles/PMC6595255/
https://europepmc.org/articles/PMC6595255/
Publikováno v:
The Journal of pediatrics. 188
To characterize children and adolescents with type 2 diabetes mellitus (T2DM) insured by a large health maintenance organization, and to identify variables associated with treatment quality and disease outcome.Children and adolescents diagnosed with